Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

Clinical Chemistry

Volumn 49, Issue 8, 2003, Pages 1381-1395

  Taieb, Joélle ^a   Mathian, Bruno ^b   Millot, Françoise ^c   Patricot, Marie Claude ^b   Mathieu, Elisabeth ^d   Queyrel, Nicole ^e   Lacroix, Isabelle ^f   Somma Delpero, Claude ^g   Boudou, Philippe ^h  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c HÔPITAL TENON   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e CENTRE HOSPITALIER DE VERSAILLES   (France)

^f LABORATOIRE CERBA   (France)

^g TIMONE HOSPITAL   (France)

^h SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; ISOTOPE DILUTION ASSAY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; RELIABILITY; SEX HORMONE DETERMINATION; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AUTOANALYSIS; CHILD; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; RADIOISOTOPE DILUTION TECHNIQUE; TESTOSTERONE;

EID: 0042868816     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.8.1381     Document Type: Article

References (55)

1. Migeon CJ, Berkovitz GD, Brown TR. Sexual differentiation and ambiguity. In: Kappy MS, Blizzard RM, Migeon CJ, eds. Endocrine disorders in childhood and adolescence. Springfield, IL: CC Thomas, 1994:573-716.
2. Wang C, Swerloff RS. Evaluation of testicular function. Balllieres Clin Endocrinol Metab 1992;6:405-34.
3. Wu FCW, Edmond P, Raab G, Hunte WM. Endocrine assessment of the subfertile male. Clin Endocrinol 1981;14:493-507.
4. Gleave ME, Goldenberg SL, Jones EC, Bruchovski N, Sullivan LD. Biochemical and pathological effects of eight months of neoadjuvant androgen withdrawal therapy before prostatectomy in patients with clinically confined prostate cancer. J Urol 1996;155:213-9.
5. Jocham D. Leuprorelin three-month depot in the treatment of advanced and metastatic prostate cancer: long-term follow-up results. Urol Int 1998;60:18-24.
6. Kuhn JM, Billebaud T, Navratil H, Moulonguet A, Fiet J, Grise P, et al. Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide). N Engl J Med 1989;321:413-8.
7. Abbou CC, Lucas C, Leblanc V. Tolerance and clinical and biological responses during the first 6 months of treatment with 1-month sustained release LHRH agonist leuprolerin and triptolerin in patients with metastatic prostate cancer. Prog Urol 1997;7:984-96.
8. Bergfeld WF. Hirsutism in women. Effective therapy that is safe for long-term use. Postgrad Med 2000;93:99-104.
9. Rosenfield RL. Pilosebaceous physiology in relation to hirsutism and acne [Review]. Clin Endocrinol Metab 1986;15:341-62.
10. Mauvais-Jarvis P, Kuttenn F, Mowszowicz I. Hirsutism. Berlin: Springer Verlag, 1981.
11. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 1999;16:394-400.
12. Rittmaster RS, Arab DM, Lehman L. Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women. Fertil Steril 1996;65:912-5.
13. Escobar-Morreale HF, San Millan JL, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril 1999;72:629-38.
14. New MI, White PC, Pang S, Dupont B, Speiser PW. The adrenal hyperplasias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic bases of inherited disease. New York: McGraw-Hill, 1989:1881-917.
15. Migeon CJ, Berkovitz GD. Congenital defects of the external genitalia in the newborn and prepubertal child. In: Carpenter SE, Rock JA, eds. Pediatric and adolescent gynecology. New York: Raven Press, 1992;77-94.
16. Brook CGD. Precocious puberty. Clin Endocrinol 1995;42:647-50.
17. Lee PA. Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 1994;148:369-76.
18. Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. Eur J Pediatr 2000;159:369-74.
19. Muller J, Juul A, Anderson AM, Sehested A, Skakkebaek NE. Hormonal changes during GnRH analogue therapy in children with central precocious puberty. J Pediatr Endocrinol Metab 2000;13:739-46.
20. Kaplowitz P. Delayed puberty in obese boys: comparison with constitutional delayed puberty and response to testosterone therapy. J Pediatr 1998;13:745-9.
21. Kulin HE, Finkelstein JW, D'Arcangelo MR, Susman EJ, Chinchilli V, Kunselman S, et al. Diversity of pubertal testosterone changes in boys: constitutional delay in growth and/or adolescence. J Pediatr Endocrinol Metab 1997;10:395-400.
22. Fuqua JS, Sher ES, Migeon CJ, Berkovitz GD. Assay of plasma testosterone during the first six months of life: importance of chromatographic purification of steroids. Clin Chem 1995;41:1146-9.
23. Siekmann L. Determination of steroid hormones by the use of isotope dilution-mass spectrometry: a definitive method in clinical chemistry. J Steroid Biochem 1979;11:117-23.
24. Lawson AM, Gaskell SJ, Hjelm M. International Federation of Clinical Chemistry (IFCC), Office for Reference Methods and Materials (ORMM). Methodological aspects on quantitative mass spectrometry used for accuracy control in clinical chemistry. J Clin Chem Clin Biochem 1985;23:433-41.
25. Fiet J, Gosling JP, Soliman M, Galon H, Boudou P, Aubin P, et al. Coordinated radioimmunoassays for eight plasma steroids relevant to the investigation of hirsutism and acne in women. Clin Chem 1994;40:2296-305.
26. Luppa P, Neumeier D. Effect of sex-hormone globulin on no-extraction immunoassays for testosterone. Clin Chem 1990;36:172-3.
27. Wudy SA, Wachter UA, Homoki J, Teller WM. 17α-Hydroxyprogesterone, 4-androstenedione, and testosterone profiled by routine stable isotope dilution/gas chromatography-mass spectrometry in plasma of children. Pediatr Res 1995;38:76-80.
28. Fitzgerald R, Herold DA. Serum total testosterone: immunoassay compared with negative chemical ionization gas chromatography-mass spectrometry. Clin Chem 1996;42:749-55.
29. Wheeler MJ, D'Souza A, Matadeen J, Croos P. Ciba Corning ACS:180 testosterone assay evaluated. Clin Chem 1996;42:1445-9.
30. Wians FH, Stuart J. Ciba Corning ACS:180 direct total testosterone assay can be used on female sera [Letter]. Clin Chem 1997;43:1466-7.
31. Boots LR, Potter S, Potter D, Azziz R. Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. Fertil Steril 1998;69:286-92.
32. Levesque A, Letellier M, Swirski C, Lee C, Grant A. Analytical evaluation of the testosterone assay on the Bayer Immuno 1 system. Clin Biochem 1998;31:23-8.
33. 13C] testosterone as internal standard. J Chromatogr 1985;339:233-42.
34. Reiffsteck A, Dehennin L, Scholler R. Estrogens in seminal plasma of human and animal species: identification and quantitative estimation by GC-MS associated with stable isotope dilution. J Steroid Biochem 1982;17:567-72.
35. Boudou P, Taieb J, Mathian B, Badonnel Y, Lacroix I, Mathieu E, et al. Comparison of progesterone concentration determination by 12 non-isotopic immunoassays and gas chromatography/mass spectrometry in 99 human serum samples. J Steroid Biochem Mol Biol 2001;78:97-104.
36. Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem 1999;45:882-94.
37. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
38. Nahoul K, Dehennin L, Scholler R. Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. J Steroid Biochem 1987;26:241-9.
39. Wheeler MJ, Lowry C. Warning on serum testosterone measurement. Lancet 1987;2:514-5.
40. Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab 1991;73:674-86.
41. Forest MG. Physiological changes in circulating androgens. In: Forest MG, ed. Androgens in childhood. Basel: Karger, 1989:104-29.
42. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, Greenhut SF. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002;67:151-8.
43. Fitzgerald RL, Herold DA. Reply: Ciba Coming ACS:180 direct total testosterone assay can be used on female sera. Clin Chem 1997;43:1467-8.
44. Gosling JP. A decade of development in immunoassay methodology. Clin Chem 1990;36:1408-27.
45. Wheeler MJ. Automated immunoassay analysers. Ann Clin Biochem 2001;38:217-29.
46. Sanchez-Carbayo M, Mauri M, Alfayate R, Miralles C, Soria F. Elecsys testosterone assay evaluated. Clin Chem 1998;44:1744-6.
47. Ognibene A, Drake CJ, Jeng KY, Pascucci TE, Hsu S, Luceri F, et al. A new modular chemiluminescence immunoassay analyser evaluated. Clin Chem Lab Med 2000;38:251-60.
48. Gonzales-Sagrado M, Martin-Gil FJ, Lopez-Hernandez S, Fernandez-Garcia N, Olmos-Linares A, Arranz-Pena ML. Reference values and methods comparison of a new testosterone assay on the AxSYM system. Clin Biochem 2000;33:175-9.
49. Jockenhövel F, Haase S, Hoermann R, Mann K. New automated direct chemiluminescent immunoassay for the determination of serum testosterone. J Clin Ligand Assay 1996;19:138-44.
50. Masters AM, Hahnel R. Investigation of sex-hormone binding globulin interference in direct radioimmunoassays for testosterone and estradiol. Clin Chem 1989;35:979-84.
51. Slaats EH, Kennedy JC, Kruijswijk H. Interference of sex-hormone binding globulin in the "Coat-A-Count" testosterone no-extraction radioimmunoassay. Clin Chem 1987;33:300-2.
52. Bodlaender P. No SHBG interference with the "Coat-A-Count Total Testosterone" direct RIA kit. Clin Chem 1990;36:173.
53. Chattoraj S. Endocrine function. In: Tietz NW, ed. Fundamentals of clinical chemistry. Philadelphia: WB Saunders, 1976:699-817.
54. Pugeat MM, Dunn JF, Nisula BC. Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:69-75.
55. Micallef JV, Hayes MM, Latif A, Ahsan R, Sufi SB. Serum binding of steroid tracers and its possible effects on direct steroid immunoassay. Ann Clin Biochem 1995;32:566-74.